Indirect Costs in Ambulatory Patients with HIV/AIDS in Spain: A Pilot Study

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.21, Iss.15, 2003-01, pp. : 1113-1121

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Indirect costs of HIV/AIDS substantial in Spain

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 433, 2003-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Economic Costs to Business of the HIV/AIDS Epidemic

By Gordon G. Liu Jeff J. Guo Scott R. Smith

PharmacoEconomics, Vol. 22, Iss. 18, 2004-01 ,pp. : 1181-1194

Adis International

Access to resources Recommend Favorite

Modelling outcomes and costs of HIV/AIDS therapy

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 360, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

The 1996 costs of patients with serious psychiatric disorders and/or HIV/AIDS are much higher than previously thought

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 585, 2009-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Economic Evaluation of Treatment Administration Strategies of Ganciclovir for Cytomegalovirus Retinitis in HIV/AIDS Patients in Thailand: A Simulation Study

By Teerawattananon Kanlaya

PharmacoEconomics, Vol. 25, Iss. 5, 2007-01 ,pp. : 413-428

Adis International

Access to resources Recommend Favorite